Fibrin turnover in lung inflammation and neoplasia

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 2, 2001, Pages 578-584

  Idell, Steven ^b   Mazar, Andrew P ^b   Bitterman, Peter ^b   Mohla, Suresh ^b   Harabin, Andrea L ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; UROKINASE; UROKINASE RECEPTOR;

ANGIOGENESIS; BLOOD CLOTTING; CONFERENCE PAPER; FIBRIN DEPOSITION; FIBRIN METABOLISM; FIBRINOLYSIS; GENE EXPRESSION REGULATION; INFLAMMATION; LUNG ENDOTHELIUM; LUNG INJURY; LUNG TUMOR; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0035132190     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.2.2005135     Document Type: Conference Paper

References (78)

1. Coagulation, fibrinolysis and fibrin deposition in lung injury and repair
2. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
3. Structural alterations of lung parenchyma in the adult respiratory distress syndrome
4. Idiopathic pulmonary fibrosis
5. Extravascular coagulation and fibrin deposition in acute lung injury (review; 91 references)
6. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis
7. Fibrin as a component of the tumor stroma: Origins and biological significance (review; 171 references)
8. Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D
9. Fibrin-mediated vascular injury: Identification of fibrin peptides that mediate endothelial cell retraction
10. Alteration of surfactant function due to protein leakage: Special interaction with fibrin monomer
11. Macrophage migration in fibrin gel matrices
12. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts: Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells
13. The plasminogen activator/plasmin system
14. Role of enzymes mediating thrombosis and thrombolysis in lung disease
15. Thrombin-induced vascular injury
16. Platelet consumption and sequestration in severe acute repiratory failure
17. Intravascular coagulation associated with the adult respiratory distress syndrome
18. Generation of mediators by limited proteolysis during blood coagulation and fibrinolysis - Its pathogenetic role in the adult respiratory distress syndrome (ARDS)
19. Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung
20. Selective cellular expression of tissue factor in human tissues: Implication for disorders of hemostasis and thrombosis
21. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
22. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
23. Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage
24. Abnormalities in pathways of fibrin turnover among patients with interstitial lung disease
25. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease
26. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury
27. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
28. Changes in procoagulant and fibrinolytic gene expression during bleomycininduced lung injury in the mouse
29. Asbestos exposure increases human bronchial epithelial cell fibrinolytic activity
30. Asbestos upregulates expression of the urokinase plasminogen activator receptor on mesothelial cells
31. Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos
32. Role of urokinase in the fibrogenic response of the lung to mineral particles
33. The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis
34. Plasminogen activators, tissue degradation, and cancer (review; 1000 references)
35. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma
36. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
37. Deregulation of the signaling pathways controlling urokinase production: Its relationship with the invasive phenotype
38. 2-terminal sequences of late stage digest fragments
39. Macromolecular substrate affinity for the tissue factor-factor VIIa complex is independent of scissile bond docking
40. Biological implications of macrophage infiltration in human tumor angiogenesis
41. Multifunctional roles of thrombin
42. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by E. coll without preventing shock or organ damage
43. Anticoagulant repertoire of the hookworm Ancylostoma caninum
44. The new anticoagulants: New opportunities, new issues
45. Antithromboric efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration
46. Surfactant alterations in severe pneumonia, ARDS and cardiogenic lung edema
47. Surfactant incorporation markedly alters mechanical properties of a fibrin clot
48. Restoration of lung compliance and prevention of lung fibrosis in a rabbit model of bleomycin induced lung fibrosis upon aerosol application of heparin and urokinase
49. Covalent antithrombin-heparin complexes with high anticoagulant activity: Intravenous, subcutaneous, and intratracheal administration
50. Blockade of extrinsic coagulation decreases lung injury in baboons with gram-negative sepsis
51. Posttranscriptional regulation of urokinase mRNA: Identification of a urokinase mRNA binding protein in lung epithelial cells in vitro
52. Posttranscriptional regulation of urokinase receptor mRNA: Identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells
53. Posttranscriptional regulation of plasminogen activator inhibitor-1 in lung carcinoma cells in vitro
54. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes
55. Regulation of integrin function by the urokinase receptor
56. Lysis of plasma clots by urokinase soluble urokinase receptor complexes
57. Urokinase-derived peptides regulate vascular smooth muscle cell contraction in vitro and in vivo
58. Augmentation of enzymatic activity upon binding to monocytes
59. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung
60. Transcriptional regulation of the interleukin-1β promotor via fibrinogen engagement of the CD18 integrin receptor
61. The urokinase receptor is required for human monocyte chemotaxis in vitro
62. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans
63. Urokinase receptor-deficient transgenic mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas infection
64. Death receptors - Signaling and modulation
65. Apoptosis - Akt is more than just a bad kinase
66. Translational control: The cancer connection
67. Translational control of programmed cell death - Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc
68. Integrin-dependent control of translation: Engagement of integrin alpha(IIb)beta(3) regulates synthesis of proteins in activated human platelets
69. Mechanism of extracellular ATP- and adenosine-induced apoptosis of cultured pulmonary artery endothelial cells
70. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
71. Adenovirus-mediated gene transfer of urokinase plasminogen activator to upregulate fibrinolysis in the murine model of bleomycin-induced pulmonary fibrosis
72. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo
73. Overexpression of urokinase receptor in breast cancer results in increased tumor invasion, growth and metastases
74. Prevention of breast cancer growth, invasion and metastases by antiestrogen tamoxifenal alone or in combination with urokinase inhibitor B-428
75. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo
76. Purified α-2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activator inhibitor-1 complex: Evidence that the α-2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes
77. Studies on the interaction of interleukin-8 (IL-8) with human plasma α-2-macroglobulin (α-2-M). Evidence for the presence of IL-8 complexed to α-2-M in lung fluids of patients with the adult respiratory distress syndrome